Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription 08.04.2024 1 Ann Surg Oncol 1 Arch Bronconeumol 6 BMC Cancer 1 Br J Cancer 1 Cancer Epidemiol Biomarkers Prev 2 Cancer Lett 2 Cancer Res 2 Clin Cancer Res 3 Clin Lung Cancer 2 Eur J Cardiothorac Surg 1 Eur Respir J 3 Int J Cancer 2 Int J Radiat Oncol Biol Phys 2 J Cancer Res Clin Oncol 2 J Clin Invest 2 J Clin Oncol 2 J Nucl Med 1 J Thorac Oncol 2 JAMA Oncol 1 Lancet 4 Lung Cancer 1 Lung Cancer (Auckl) 1 Mol Cancer Ther 2 Oncogene 1 Oncologist 4 PLoS One 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. LIU J, Shi Z, Cao B, Wang Z, et al
   ASO Author Reflections: The Prognostic Significance of the Highest Mediastinal Lymph Node Involvement in Non-small Cell Lung Cancer Patients.
   Ann Surg Oncol. 2024 Apr 4. doi: 10.1245/s10434-024-15243.
   PubMed        
   
   

   
   Arch Bronconeumol

2. GOROSPE L, Gomez-Bermejo MA, Mirambeaux-Villalona RM
   Partial Anomalous Pulmonary Venous Return Incidentally Detected at Lung Cancer Screening With Low-dose Thoracic CT.
   Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00071.
   PubMed        
   
   

   
   BMC Cancer

3. BOUTABBA A, Missaoui F, Dlala A, Kamoun H, et al
   Circulating miR-16-5p, miR-92a-3p and miR-451a are biomarkers of lung cancer in Tunisian patients.
   BMC Cancer. 2024;24:417.
   PubMed         Abstract available
   
   
4. DIVAN HA, Bittoni MA, Krishna A, Carbone DP, et al
   Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer.
   BMC Cancer. 2024;24:424.
   PubMed         Abstract available
   
   
5. MENNECIER B, Khalifa J, Descourt R, Greillier L, et al
   Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method study.
   BMC Cancer. 2024;24:421.
   PubMed         Abstract available
   
   
6. ZENG A, Yin Y, Xu Z, Abuduwayiti A, et al
   Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD).
   BMC Cancer. 2024;24:396.
   PubMed         Abstract available
   
   
7. YANG F, Zheng Y, Luo Q, Zhang S, et al
   Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway.
   BMC Cancer. 2024;24:408.
   PubMed         Abstract available
   
   
8. SHENG M, Sun R, Fu J, Lu G, et al
   The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
   BMC Cancer. 2024;24:399.
   PubMed         Abstract available
   
   

   
   Br J Cancer

9. KANAHORI M, Shimada E, Matsumoto Y, Endo M, et al
   Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8(+) T cell infiltration.
   Br J Cancer. 2024;130:1083-1095.
   PubMed         Abstract available
   
   

   
   Cancer Epidemiol Biomarkers Prev

10. ALLAIRE BT, Horvath ML, Lines LM, Davidoff AJ, et al
    Do Contemporary Cancer Survivors Experience Better Quality of Life? Evaluating a Decade of SEER Medicare Health Outcomes Survey Data.
    Cancer Epidemiol Biomarkers Prev. 2024;33:593-599.
    PubMed         Abstract available
    
    

    
    Cancer Lett

11. GAO GB, Chen L, Pan JF, Lei T, et al
    LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer.
    Cancer Lett. 2024 Apr 2:216826. doi: 10.1016/j.canlet.2024.216826.
    PubMed         Abstract available
    
    
12. HAO Z, Xin Z, Chen Y, Shao Z, et al
    JAML promotes the antitumor role of tumor-resident CD8(+) T cells by facilitating their innate-like function in human lung cancer.
    Cancer Lett. 2024 Apr 1:216839. doi: 10.1016/j.canlet.2024.216839.
    PubMed         Abstract available
    
    

    
    Cancer Res

13. LIU Y, Murazzi I, Fuller AM, Pan H, et al
    Sarcoma Cells Secrete Hypoxia-Modified Collagen VI to Weaken the Lung Endothelial Barrier and Promote Metastasis.
    Cancer Res. 2024;84:977-993.
    PubMed         Abstract available
    
    
14. XU Y, Deng C, Chen H, Song Y, et al
    Osteosarcoma Cells Secrete CXCL14 That Activates Integrin alpha11beta1 on Fibroblasts to Form a Lung Metastatic Niche.
    Cancer Res. 2024;84:994-1012.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

15. SINGH AK, Lewis CD, Boas CAWV, Diebolder P, et al
    Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library.
    Clin Cancer Res. 2024;30:1293-1306.
    PubMed         Abstract available
    
    
16. VAIDYA P, Cohen EEW
    Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence.
    Clin Cancer Res. 2024;30:1232-1239.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

17. GEORGE B, Baydoun A, Bhat S, Bailey L, et al
    Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer - Results from a Single Institution Study.
    Clin Lung Cancer. 2024 Feb 24:S1525-7304(24)00030.
    PubMed         Abstract available
    
    
18. MOGHANAKI D, Taylor J, Bryant AK, Vitzthum LK, et al
    Lung Cancer Survival Trends in the Veterans Health Administration.
    Clin Lung Cancer. 2024 Mar 2:S1525-7304(24)00035.
    PubMed         Abstract available
    
    
19. KHOKHAR B, Chiang B, Iglay K, Reynolds K, et al
    QT-Interval Prolongation, Torsades de Pointes, and Heart Failure With EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Systematic Review.
    Clin Lung Cancer. 2024 Feb 17:S1525-7304(24)00016.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

20. CHARLOUX A, Olland A, Falcoz PE
    Minute ventilation to carbon dioxide slope and risk stratification before lung cancer resection.
    Eur J Cardiothorac Surg. 2024 Apr 5:ezad390. doi: 10.1093.
    PubMed        
    
    
21. LAMPRIDIS S
    Optimising care in obese lung cancer patients undergoing lobectomy: Analysing complications by surgical approach.
    Eur J Cardiothorac Surg. 2024 Apr 1:ezae129. doi: 10.1093.
    PubMed        
    
    

    
    Eur Respir J

22. BRUDON A, Legendre M, Mageau A, Bermudez J, et al
    High risk of lung cancer in surfactant-related gene variant carriers.
    Eur Respir J. 2024 Apr 4:2301809. doi: 10.1183/13993003.01809-2023.
    PubMed         Abstract available
    
    

    
    Int J Cancer

23. SEBASTIAN M, Eberhardt WEE, von der Heyde E, Dorfel S, et al
    Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315).
    Int J Cancer. 2024;154:1967-1978.
    PubMed         Abstract available
    
    
24. GU Z, Huang P, Zhao J, Luo C, et al
    Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs.
    Int J Cancer. 2024;154:1979-1986.
    PubMed         Abstract available
    
    
25. LIU X, Xie X, Sui C, Liu X, et al
    Unraveling the cross-talk between N6-methyladenosine modification and non-coding RNAs in breast cancer: Mechanisms and clinical implications.
    Int J Cancer. 2024 Mar 1. doi: 10.1002/ijc.34900.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

26. KIM KH, Kang N, Song SY, Kim HJ, et al
    Safety and efficacy of HL301 in radiation pneumonitis in patients with unresectable non-small cell lung cancer receiving curative concurrent chemoradiotherapy: A multicenter, randomized, double-blinded, placebo-controlled, phase IIa clinical trial.
    Int J Radiat Oncol Biol Phys. 2024 Mar 31:S0360-3016(24)00447.
    PubMed         Abstract available
    
    
27. HUANG HT, Brand DH, Fenwick JD, Hawkins MA, et al
    Immuno-chemoradiation for non-small cell lung cancer: A meta-analysis of factors influencing survival benefit in combination trials.
    Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00449.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

28. SAKASHITA M, Motoi N, Yamamoto G, Gambe E, et al
    An algorithm-based technique for counting mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections.
    J Cancer Res Clin Oncol. 2024;150:172.
    PubMed         Abstract available
    
    
29. ZHAO R, Guan X, Zhang P, Liu Y, et al
    Development of postoperative bronchopleural fistula after neoadjuvant immunochemotherapy in non-small cell lung cancer: case reports and review of the literature.
    J Cancer Res Clin Oncol. 2024;150:175.
    PubMed         Abstract available
    
    

    
    J Clin Invest

30. TAN AC, Cook SL, Khasraw M
    Soluble immune-checkpoint factors: a potential immunotherapy biomarker.
    J Clin Invest. 2024;134:e179352.
    PubMed         Abstract available
    
    
31. HAYASHI H, Chamoto K, Hatae R, Kurosaki T, et al
    Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.
    J Clin Invest. 2024;134:e168318.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

32. NEAL J, Pavlakis N, Kim SW, Goto Y, et al
    CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
    J Clin Oncol. 2024 Mar 29:JCO2302166. doi: 10.1200/JCO.23.02166.
    PubMed         Abstract available
    
    
33. DAI W, Wang Y, Liao J, Wei X, et al
    Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial.
    J Clin Oncol. 2024 Apr 4:JCO2301854. doi: 10.1200/JCO.23.01854.
    PubMed         Abstract available
    
    

    
    J Nucl Med

34. LEUNG KH, Rowe SP, Sadaghiani MS, Leal JP, et al
    Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT.
    J Nucl Med. 2024 Feb 29:jnumed.123.267048. doi: 10.2967/jnumed.123.267048.
    PubMed         Abstract available
    
    
35. SCHULER M, Hense J, Darwiche K, Michels S, et al
    Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.
    J Nucl Med. 2024 Apr 4:jnumed.123.266979. doi: 10.2967/jnumed.123.266979.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

36. DETTERBECK FC, Ostrowski M, Hoffmann H, Rami-Porta R, et al
    The IASLC Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor after Resection for the Forthcoming (9(th)) Edition of the TNM Classification of Lung Cancer.
    J Thorac Oncol. 2024 Apr 1:S1556-0864(24)00129.
    PubMed         Abstract available
    
    

    
    JAMA Oncol

37. AKAMATSU H
    Locally Advanced Relapse May Not Be Equal to Stage 3 Non-Small Cell Lung Cancer.
    JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0231.
    PubMed        
    
    
38. TACHIHARA M, Tsujino K
    Locally Advanced Relapse May Not Be Equal to Stage 3 Non-Small Cell Lung Cancer-Reply.
    JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0234.
    PubMed        
    
    

    
    Lancet

39. MUROYA D, Morimitsu Y, Nakamura K, Hayashi K, et al
    Hidden metastatic lung tumour diagnosed by AI.
    Lancet. 2024;403:1290.
    PubMed        
    
    

    
    Lung Cancer

40. PU X, Xiao Z, Li J, Wu Z, et al
    Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial.
    Lung Cancer. 2024;191:107538.
    PubMed         Abstract available
    
    
41. GUDINA AT, Kamen C, Hardy SJ, Kehoe L, et al
    Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
    Lung Cancer. 2024;191:107539.
    PubMed         Abstract available
    
    
42. LYHNE CHRISTENSEN N, Gouliaev A, McPhail S, Lyratzopoulos G, et al
    Lung cancer among the Elderly in Denmark - A comprehensive population-based cohort study.
    Lung Cancer. 2024;191:107555.
    PubMed         Abstract available
    
    
43. GABRIEL L, McVeigh T, Macmahon S, Avila Z, et al
    Familial rare EGFR-mutant lung cancer syndrome: Review of literature and description of R776H family.
    Lung Cancer. 2024;191:107543.
    PubMed         Abstract available
    
    

    
    Lung Cancer (Auckl)

44. DOU XJ, Ma RY, Ren DW, Liu Q, et al
    Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study.
    Lung Cancer (Auckl). 2024;15:29-40.
    PubMed         Abstract available
    
    

    
    Mol Cancer Ther

45. LULLA AR, Akli S, Karakas C, Caruso JA, et al
    Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis.
    Mol Cancer Ther. 2024;23:492-506.
    PubMed         Abstract available
    
    

    
    Oncogene

46. HEIM TE, Hankins ML, Belayneh R, Douglas N, et al
    RNA-sequencing predicts a role of androgen receptor and aldehyde dehydrogenase 1A1 in osteosarcoma lung metastases.
    Oncogene. 2024;43:1007-1018.
    PubMed         Abstract available
    
    
47. MCCLELLAN B, Wilson CN, Brenner AJ, Jolly CA, et al
    Flotillin-1 palmitoylation is essential for its stability and subsequent tumor promoting capabilities.
    Oncogene. 2024;43:1063-1074.
    PubMed         Abstract available
    
    

    
    Oncologist

48. ALLENDE S, Turcott JG, Verastegui E, Rodriguez-Mayoral O, et al
    Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial.
    Oncologist. 2024 Apr 1:oyae050. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    PLoS One

49. HAN H, Huang H, Chen AP, Tang Y, et al
    High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
    PLoS One. 2024;19:e0292726.
    PubMed         Abstract available
    
    
50. ZHANG Y, Liu H, Chang C, Yin Y, et al
    Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
    PLoS One. 2024;19:e0300170.
    PubMed         Abstract available
    
    
51. LV M, Li X, Yin Z, Yang H, et al
    Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
    PLoS One. 2024;19:e0294227.
    PubMed         Abstract available
    
    
52. LE ROUX O, Everitt JI, Counter CM
    p53 dosage can impede KrasG12D- and KrasQ61R-mediated tumorigenesis.
    PLoS One. 2024;19:e0292189.
    PubMed         Abstract available
    
    

    
    Thorax

53. SHAH PL
    Ablation for lung cancer: hot or cold intervention.
    Thorax. 2024 Apr 4:thorax-2023-221369. doi: 10.1136/thorax-2023-221369.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.